Association of oxidative stress on pregnancy

K Toboła-Wróbel, M Pietryga… - Oxidative medicine …, 2020 - Wiley Online Library
The pathophysiological mechanism underlying pregnancy complications such as congenital
malformations, miscarriage, preeclampsia, or fetal growth restriction is not entirely known …

[HTML][HTML] Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets

A Izzo, N Mollo, M Nitti, S Paladino, G Calì… - Molecular …, 2018 - Springer
Abstract Trisomy of chromosome 21 (TS21) is the most common autosomal aneuploidy
compatible with postnatal survival with a prevalence of 1 in 700 newborns. Its phenotype is …

Lysosomal dysfunction in Down syndrome is APP-dependent and mediated by APP-βCTF (C99)

Y Jiang, Y Sato, E Im, M Berg, M Bordi… - Journal of …, 2019 - Soc Neuroscience
Lysosomal failure underlies pathogenesis of numerous congenital neurodegenerative
disorders and is an early and progressive feature of Alzheimer's disease (AD) pathogenesis …

[HTML][HTML] Down syndrome is a metabolic disease: altered insulin signaling mediates peripheral and brain dysfunctions

M Dierssen, M Fructuoso… - Frontiers in …, 2020 - frontiersin.org
Down syndrome (DS) is the most frequent chromosomal abnormality that causes intellectual
disability, resulting from the presence of an extra complete or segment of chromosome 21 …

[HTML][HTML] The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down …

D Valenti, L de Bari, D de Rasmo, A Signorile… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Mitochondrial dysfunctions critically impair nervous system development and are potentially
involved in the pathogenesis of various neurodevelopmental disorders, including Down …

Down syndrome: Neurobiological alterations and therapeutic targets

RA Vacca, S Bawari, D Valenti, D Tewari… - Neuroscience & …, 2019 - Elsevier
Down syndrome (DS) is a genetic disease that occurs due to an aneuploidy of human
chromosome 21. Trisomy of chromosome 21 is a primary genetic cause of developmental …

[HTML][HTML] Metformin in therapeutic applications in human diseases: Its mechanism of action and clinical study

Y Du, YJ Zhu, YX Zhou, J Ding, JY Liu - Molecular Biomedicine, 2022 - Springer
Metformin, a biguanide drug, is the most commonly used first-line medication for type 2
diabetes mellites due to its outstanding glucose-lowering ability. After oral administration of …

Mitochondria as pharmacological targets in Down syndrome

D Valenti, N Braidy, D De Rasmo, A Signorile… - Free Radical Biology …, 2018 - Elsevier
Mitochondria play a pivotal role in cellular energy-generating processes and are considered
master regulators of cell life and death fate. Mitochondrial function integrates signalling …

Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome

E Lana-Elola, R Aoidi, M Llorian, D Gibbins… - Science translational …, 2024 - science.org
Down syndrome (DS) is caused by trisomy of human chromosome 21 (Hsa21). DS is a gene
dosage disorder that results in multiple phenotypes including congenital heart defects. This …

Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells

A Izzo, M Nitti, N Mollo, S Paladino… - Human molecular …, 2017 - academic.oup.com
Alterations in mitochondrial activity and morphology have been demonstrated in human
cells and tissues from individuals with Down syndrome (DS), as well as in DS mouse …